Health In Tech (Nasdaq: HIT) ties executive RSAs to new programs

Rhea-AI Filing Summary

Health In Tech, Inc. reported that its Compensation Committee approved new restricted stock awards for three senior executives tied to the development of two new programs, referred to as Program 1 and Program 2. Chief Executive Officer Tim Johnson was granted 17,000 shares for each program, Chief Financial Officer Linlin (Julia) Qian was granted 10,000 shares for Program 1 and 17,000 shares for Program 2, and Chief Technology Officer (Mo) Imran Yousuf was granted 3,500 shares for each program.

Half of each executive’s grant will vest in equal monthly installments over twelve months starting when the first of the two programs is successfully launched and fully operational in the marketplace. The remaining half will vest in equal monthly installments over twelve months starting when the other program is successfully launched and fully operational. These awards were made under the company’s Equity Incentive Plan and follow previously approved restricted stock award agreements.

false 0002019505 0002019505 2025-08-15 2025-08-15 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

Current Report

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

August 15, 2025

Date of Report (Date of earliest event reported)

Health In Tech, Inc.

(Exact name of registrant as specified in its charter)

Nevada		001-42449		87-3545722
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification No.)

701 S. Colorado Ave, Suite 1 Stuart, FL		34994
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code: (888) 373-0333

N/A

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Class A Common Stock, $0.001 par value per share		HIT		The Nasdaq Stock Market LLC (Nasdaq Capital Market)

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On August 15, 2025, the Compensation Committee of the Board of Directors of Health In Tech, Inc., a Nevada corporation (the “Company”), approved the grant of restricted stock awards (the “RSAs”) to Tim Johnson, the Company’s Chief Executive Officer, Linlin (Julia) Qian, the Company’s Chief Financial Officer, and (Mo) Imran Yousuf, the Company’s Chief Technology Officer. The Company granted the RSAs to Mr. Johnson, Ms. Qian and Mr. Yousef in connection with services these named executive officers are providing to the Company to develop two new programs, which are referred to in this Current Report on Form 8-K as “Program 1” and “Program 2”, and collectively as, the “Programs”. Mr. Johnson received a grant of 17,000 shares of restricted stock in connection with Program 1 and 17,000 shares of restricted stock in connection with Program 2. Ms. Qian received a grant of 10,000 shares of restricted stock in connection with Program 1 and 17,000 shares of restricted stock in connection with Program 2. Mr. Yousuf received a grant of 3,500 shares of restricted stock in connection with Program 1 and 3,500 shares of restricted stock in connection with Program 2. Fifty percent (50%) of the total number of shares of restricted stock granted to each recipient shall vest in equal monthly installments over a twelve (12) month period commencing on the date that the first of the two Programs is successfully launched and fully operational in the marketplace, and the remaining fifty percent (50%) shall vest in equal monthly installments over a twelve (12) month period commencing on the date that the other Program is successfully launched and fully operational in the marketplace. The RSAs were granted pursuant to the Health In Tech, Inc. Equity Incentive Plan and are subject to the terms and conditions set forth in the Restricted Stock Award Agreements previously approved by the Compensation Committee.

1

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: August 19, 2025

HEALTH IN TECH, INC.

By:	/s/ Tim Johnson
Name:	Tim Johnson
Title:	Chief Executive Officer

2

FAQ

What executive equity awards did Health In Tech (HIT) just approve?

Health In Tech approved restricted stock awards (RSAs) for its Chief Executive Officer, Chief Financial Officer, and Chief Technology Officer in connection with developing two new programs.

How many restricted shares did each Health In Tech executive receive?

Tim Johnson received 17,000 shares for Program 1 and 17,000 for Program 2. Linlin (Julia) Qian received 10,000 shares for Program 1 and 17,000 for Program 2. (Mo) Imran Yousuf received 3,500 shares for Program 1 and 3,500 for Program 2.

What are the vesting conditions for the new Health In Tech RSAs?

For each executive, 50% of the restricted shares vest in equal monthly installments over 12 months starting on the date the first program is successfully launched and fully operational. The remaining 50% vest in equal monthly installments over 12 months starting on the date the other program is successfully launched and fully operational.

Which plan governs the new restricted stock awards at Health In Tech (HIT)?

The RSAs were granted under the Health In Tech, Inc. Equity Incentive Plan and are subject to the terms of previously approved Restricted Stock Award Agreements.

Why did Health In Tech grant these restricted stock awards?

The awards were granted in connection with services provided by the named executive officers to develop two new programs, referred to as Program 1 and Program 2.

Does the 8-K report any departures of Health In Tech officers or directors?

No departures are described. The Item 5.02 disclosure focuses on compensatory arrangements, specifically new restricted stock awards for the CEO, CFO, and CTO.